The serum levels of SAA1, FGA, and SAP in the EGPA group were significantly elevated as compared to the healthy control and severe-asthma groups (Figures 4A–C), while the serum CETP was significantly lower in the EGPA group compared with the severe-asthma group (Figure 4D). The gene discussed is SAA1; the disease is asthma.